OBJECTIVE The activation of the complement system may be involved in the pathology of
myocardial infarction (MI) and type 2 diabetes. To explore their potential as prognostic …

Background Acute myocardial infarction (AMI) is a potentially fatal condition, being a major
cause of death worldwide. Ischemia suffered during AMI causes tissue damage, leading to …

OBJECTIVE Immune dysregulation can affect insulin resistance (IR) and β-cell function and
hence contribute to development of type 2 diabetes mellitus (T2DM). The complement …

Context Impairment of immune and inflammatory homeostasis is reported to be one of the
causal factors of diabetes. However, the association of complement C3 levels with incident …

Cross-sectional studies have reported strong correlations between plasma levels of
complement C3, insulin, and glucose. This prospective study explored whether elevated …

Background The positive effect of reperfusion after ST-elevation myocardial infarction
(STEMI) can be reduced by ischemic/reperfusion (I/R) injury. Mannose-binding-lectin (MBL) …

OBJECTIVE To test the hypothesis that the complement system may be activated in patients
with type II diabetes and CAD. RESEARCH DESIGN AND METHODS The plasma C3d …

Diabet. Med. 29, 470–478 (2012) Abstract Aims Systemic concentrations of adhesion
molecules and chemokines are associated with increased risk of cardiovascular …

Aims Heart failure (HF) is an impending complication to myocardial infarction. We
hypothesized that the degree of complement activation reflects severity of HF following acute …

Aims To investigate whether serum complement C3 is related to the prevalence and
incidence of prediabetes in an adult population. Methods A cross‐sectional (n= 10 206) and …